![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
https://www.fiercepharma.com/pharma/glp-1-drugs-novo-az-lilly-and-sanofi-under-uk-probe-over-their-suicide-risks-reuters
https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-weekly-once-diabetes-drug-gets-us-approval-children-2021-07-23/
HTTPS://WWW.IN-PHARMATECHNOLOGIST.COM/ARTICLE/2019/11/04/ASTRAZENECA-SALES-HURT-BY-BYDUREON-BCISE-PRODUCTION-CONSTRAINTS
https://www.fiercebiotech.com/biotech/longtime-alkermes-exec-elliot-ehrich-joins-expansion-therapeutics
https://www.xconomy.com/indiana/2018/09/27/eli-lilly-strikes-deal-for-diabetes-pill-to-gain-on-novo-nordisk/
http://www.pharmatimes.com/news/eu_approves_az_bydureon_bcise_device_1250738
https://www.fiercebiotech.com/research/repurposing-glp-1-diabetes-drug-to-slow-parkinson-s-disease
https://www.biospectrumasia.com/news/25/11292/new-sr-exendin-4-formulation-proves-effective-against-parkinsons.html
https://pharmaphorum.com/news/az-hopes-diabetes-drug-could-be-as-effective-as-gastric-band/
http://www.fiercepharma.com/pharma/lilly-s-adhd-med-strattera-faces-new-generic-competition-from-teva-and-others
http://pharmaphorum.com/news/intarcias-mini-pump-gets-fda-go-ahead-type-2-diabetes/
http://www.pharmatimes.com/news/glide_raises_3.2m_for_solid_dose_injector_programme_1185653
http://www.fiercebiotech.com/research/platypus-venom-could-give-rise-to-a-new-class-diabetes-treatments
http://www.nasdaq.com/article/oramed-vs-novo-nordisk-in-race-for-oral-glp-1-cm715418
http://www.fiercepharma.com/pharma-asia/az-taps-3sbio-for-help-driving-sales-two-diabetes-drugs-china
http://www.fiercebiotech.com/biotech/eli-lilly-spurns-a-phiii-ready-diabetes-drug-and-transition-tanks-again
http://www.prnewswire.com/news-releases/glide-technologies-announces-successful-proof-of-concept-with-novel-exenatide-solid-dose-formulation-564345691.html
http://blogs.wsj.com/pharmalot/2015/04/01/should-fda-penalize-drug-makers-over-diabetes-drug-ads/
http://www.fiercepharma.com/story/sanofis-diabetes-franchise-one-step-closer-us-lyxumia-launch/2015-03-19
http://www.pharmatimes.com/Article/15-01-27/AZ_launches_Bydureon_pre-filled_injector_pen_in_UK.aspx